Loading...

Abbvie Inc (NYSE:ABBV)

152.34 USD +2.89 USD ( +1.93% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

EV/EBITDA
Enterprise Value to EBITDA

The Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
=
Enterprise Value
/
EBITDA
Current EV/EBITDA
ABBV
11.4
Median EV/EBITDA
ABBV
10.4
Industry EV/EBITDA
Biotechnology
2.2

EV/EBITDA History

Statistics
Enterprise Value to EBITDA

1 Year 3 Years 5 Years
Average 10.7 10.7 11.1
Median 10.5 10.4 11
Min 9.4 7.5 7.5
Max 12 15.5 15.5

History Chart
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.1
2-Years Forward
EV/EBITDA
11.9
3-Years Forward
EV/EBITDA
12

EV/EBITDA Across Competitors

ABBV Competitors
Abbvie Inc Competitors

Country Company Market Cap EV/EBITDA
US
Abbvie Inc
NYSE:ABBV
269B USD 11.4
US
Amgen Inc
NASDAQ:AMGN
131B USD 20
AU
CSL Ltd
ASX:CSL
128B AUD 24.7
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 7.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 21.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.1B USD 6.7

Relative Valuation Report

View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.

See Also

Similar Stocks